Two cases of psoriasis following growth hormone therapy

Young Soo Heo, Se Yeong Jeong, Jae Eun Choi, Soo-Hong Seo, Hyo Hyun Ahn, Young Chul Kye

Research output: Contribution to journalArticle

Abstract

Growth hormone (GH) has been available for more than 4 decades for the treatment of GH deficiency. But mass production of recombinant DNA growth hormone has made GH therapy widely available for children with no GH deficiency. The use of GH merapy in children has resulted in adverse effects ranging from minor disturbances such as edema and injection site reactions to more significant, but rare events such as benign intracranial hypertension and slipped capital femoral epiphysis. Yet there has been no report in the dermatological field on skin adverse effects associated with GH therapy. We report here on 2 cases of psoriasis following GH therapy in children.

Original languageEnglish
Pages (from-to)714-717
Number of pages4
JournalKorean Journal of Dermatology
Volume47
Issue number6
Publication statusPublished - 2009 Jun 1

Fingerprint

Psoriasis
Growth Hormone
Therapeutics
Slipped Capital Femoral Epiphyses
Pseudotumor Cerebri
Recombinant DNA
Edema
Skin
Injections

Keywords

  • Growth hormone
  • Insulin-like growth factor
  • Psoriasis

ASJC Scopus subject areas

  • Dermatology

Cite this

Two cases of psoriasis following growth hormone therapy. / Heo, Young Soo; Jeong, Se Yeong; Choi, Jae Eun; Seo, Soo-Hong; Ahn, Hyo Hyun; Kye, Young Chul.

In: Korean Journal of Dermatology, Vol. 47, No. 6, 01.06.2009, p. 714-717.

Research output: Contribution to journalArticle

Heo, Young Soo ; Jeong, Se Yeong ; Choi, Jae Eun ; Seo, Soo-Hong ; Ahn, Hyo Hyun ; Kye, Young Chul. / Two cases of psoriasis following growth hormone therapy. In: Korean Journal of Dermatology. 2009 ; Vol. 47, No. 6. pp. 714-717.
@article{aa4e8ec55ef14adca453ce8df01692a7,
title = "Two cases of psoriasis following growth hormone therapy",
abstract = "Growth hormone (GH) has been available for more than 4 decades for the treatment of GH deficiency. But mass production of recombinant DNA growth hormone has made GH therapy widely available for children with no GH deficiency. The use of GH merapy in children has resulted in adverse effects ranging from minor disturbances such as edema and injection site reactions to more significant, but rare events such as benign intracranial hypertension and slipped capital femoral epiphysis. Yet there has been no report in the dermatological field on skin adverse effects associated with GH therapy. We report here on 2 cases of psoriasis following GH therapy in children.",
keywords = "Growth hormone, Insulin-like growth factor, Psoriasis",
author = "Heo, {Young Soo} and Jeong, {Se Yeong} and Choi, {Jae Eun} and Soo-Hong Seo and Ahn, {Hyo Hyun} and Kye, {Young Chul}",
year = "2009",
month = "6",
day = "1",
language = "English",
volume = "47",
pages = "714--717",
journal = "Korean Journal of Dermatology",
issn = "0494-4739",
publisher = "Korean Dermatological Association",
number = "6",

}

TY - JOUR

T1 - Two cases of psoriasis following growth hormone therapy

AU - Heo, Young Soo

AU - Jeong, Se Yeong

AU - Choi, Jae Eun

AU - Seo, Soo-Hong

AU - Ahn, Hyo Hyun

AU - Kye, Young Chul

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Growth hormone (GH) has been available for more than 4 decades for the treatment of GH deficiency. But mass production of recombinant DNA growth hormone has made GH therapy widely available for children with no GH deficiency. The use of GH merapy in children has resulted in adverse effects ranging from minor disturbances such as edema and injection site reactions to more significant, but rare events such as benign intracranial hypertension and slipped capital femoral epiphysis. Yet there has been no report in the dermatological field on skin adverse effects associated with GH therapy. We report here on 2 cases of psoriasis following GH therapy in children.

AB - Growth hormone (GH) has been available for more than 4 decades for the treatment of GH deficiency. But mass production of recombinant DNA growth hormone has made GH therapy widely available for children with no GH deficiency. The use of GH merapy in children has resulted in adverse effects ranging from minor disturbances such as edema and injection site reactions to more significant, but rare events such as benign intracranial hypertension and slipped capital femoral epiphysis. Yet there has been no report in the dermatological field on skin adverse effects associated with GH therapy. We report here on 2 cases of psoriasis following GH therapy in children.

KW - Growth hormone

KW - Insulin-like growth factor

KW - Psoriasis

UR - http://www.scopus.com/inward/record.url?scp=70349232910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349232910&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 714

EP - 717

JO - Korean Journal of Dermatology

JF - Korean Journal of Dermatology

SN - 0494-4739

IS - 6

ER -